PT Fapon Bioindustries Indonesia and the Indonesian state-owned pharmaceutical holding company PT Bio Farma (Persero) have signed a cooperation agreement. The partnership is centered on the local manufacturing, and commercialisation of IVD products in Indonesia.
Dyah, Chief Executive Officer of Fapon Indonesia Market, and Dicky, Head of the Business Development Division at Bio Farma, formally executed the agreement on behalf of their respective organisations. This collaboration represents a major advancement in localising diagnostic technologies and upgrading Indonesia's healthcare industry.
PT Fapon is Fapon Group's first overseas manufacturing base, dedicated to supplying the Indonesian and regional markets with diagnostic products and solutions that meet international standards. While Bio Farma, with a legacy spanning over 130 years, is a leading national life science enterprise in Indonesia, boasting extensive expertise in the research, development, production, and distribution of vaccines, biologics, and pharmaceutical products.
This partnership marks a significant milestone in PT Fapon's strategy to deepen its local roots and empower the autonomous development of Indonesia's medical industry. Looking ahead, both parties plan to explore further collaborative opportunities in medical innovation and technology transferring, jointly driving progress in healthcare across Indonesia and Southeast Asia.
